日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer

IFCT-1502 CLINIVO:一项全国性晚期非小细胞肺癌患者队列研究,提供了纳武利尤单抗治疗长期生存的真实世界证据

Molinier, O; Besse, B; Barlesi, F; Audigier-Valette, C; Friard, S; Monnet, I; Jeannin, G; Mazières, J; Cadranel, J; Hureaux, J; Hilgers, W; Quoix, E; Coudert, B; Moro-Sibilot, D; Fauchon, E; Westeel, V; Brun, P; Langlais, A; Morin, F; Souquet, P J; Girard, N

Lorlatinib for advanced ROS1+ non-small-cell lung cancer: results of the IFCT-1803 LORLATU study

劳拉替尼治疗晚期 ROS1+ 非小细胞肺癌:IFCT-1803 LORLATU 研究结果

Girard, N; Galland-Girodet, S; Avrillon, V; Besse, B; Duruisseaux, M; Cadranel, J; Otto, J; Prevost, A; Roch, B; Bennouna, J; Bouledrak, K; Coudurier, M; Egenod, T; Lamy, R; Ricordel, C; Moro-Sibilot, D; Odier, L; Tillon-Strozyk, J; Zalcman, G; Missy, P; Westeel, V; Baldacci, S

Daily multidisciplinary COVID-19 meeting: Experiences from a French university hospital

每日多学科新冠肺炎会议:来自法国一家大学医院的经验

Rolland-Debord, C; Canellas, A; Choinier, P; Milon, A; Debrix, I; Blin, E; Belaube, N; Mattioni, S; Millet, F; Nadal, M; Petit-Hoang, C; Rigaud, P; Rech, J S; Siguier, M; Sroussi, D; Denis, M; Amiel, C; Fartoukh, M; Georgin-Lavialle, S; Lassel, L; Parrot, A; Cadranel, J

NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents

NRG1融合驱动肿瘤:生物学、检测以及阿法替尼和其他ErbB靶向药物的治疗作用

Laskin, J; Liu, S V; Tolba, K; Heining, C; Schlenk, R F; Cheema, P; Cadranel, J; Jones, M R; Drilon, A; Cseh, A; Gyorffy, S; Solca, F; Duruisseaux, M

Proposals for managing patients with thoracic malignancies during COVID-19 pandemic

关于 COVID-19 大流行期间胸部恶性肿瘤患者管理的建议

Girard, N; Greillier, L; Zalcman, G; Cadranel, J; Moro-Sibilot, D; Mazières, J; Audigier-Valette, C; Bennouna, J; Besse, B; Cortot, A; Couraud, S; Duruisseaux, M; Giroux-Leprieur, E; Toffart, A-C; Westeel, V; Wislez, M

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)†

一项随机 II 期研究,比较 MEK1/MEK2 抑制剂曲美替尼 (GSK1120212) 与多西他赛在 KRAS 突变型晚期非小细胞肺癌 (NSCLC) 中的疗效†

Blumenschein, G R Jr; Smit, E F; Planchard, D; Kim, D-W; Cadranel, J; De Pas, T; Dunphy, F; Udud, K; Ahn, M-J; Hanna, N H; Kim, J-H; Mazieres, J; Kim, S-W; Baas, P; Rappold, E; Redhu, S; Puski, A; Wu, F S; Jänne, P A

Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network

法国ERMETIC-IFCT网络开展的一项多中心观察性研究,纳入10117例非小细胞肺癌患者,探讨了EGFR 18号外显子和20号外显子罕见突变的发生情况。

Beau-Faller, M; Prim, N; Ruppert, A-M; Nanni-Metéllus, I; Lacave, R; Lacroix, L; Escande, F; Lizard, S; Pretet, J-L; Rouquette, I; de Crémoux, P; Solassol, J; de Fraipont, F; Bièche, I; Cayre, A; Favre-Guillevin, E; Tomasini, P; Wislez, M; Besse, B; Legrain, M; Voegeli, A-C; Baudrin, L; Morin, F; Zalcman, G; Quoix, E; Blons, H; Cadranel, J

Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial

伏立康唑治疗慢性肺曲霉病:一项前瞻性多中心试验

Cadranel, J; Philippe, B; Hennequin, C; Bergeron, A; Bergot, E; Bourdin, A; Cottin, V; Jeanfaivre, T; Godet, C; Pineau, M; Germaud, P

Lung cancer in HIV infected patients: facts, questions and challenges

HIV感染者肺癌:事实、问题与挑战

Cadranel, J; Garfield, D; Lavolé, A; Wislez, M; Milleron, B; Mayaud, C

Impairment of beta chemokine and cytokine production in patients with HIV related Pneumocystis jerovici pneumonia.

HIV相关耶氏肺孢子虫肺炎患者β趋化因子和细胞因子生成受损

Israël-Biet D, Esvant H, Laval A M, Cadranel J